Albemarle Corporation revised earnings guidance for the fiscal year 2022. For the period, the company expects net sales to be in the range of $7.1 billion and $7.5 billion against previously announced net sales of $5.8 billion and $6.2 billion.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
99.54 USD | -1.08% |
|
-12.66% | -31.10% |
06-18 | Chile lithium projects garner interest from over 50 companies | RE |
06-18 | Factbox-China's Premier Li visits industry in Western Australia | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.10% | 11.7B | |
+22.66% | 69.48B | |
-6.21% | 46.41B | |
+22.70% | 45.06B | |
+30.65% | 28.24B | |
+7.64% | 19.54B | |
+14.21% | 17.32B | |
-10.45% | 15.2B | |
-25.49% | 14.49B | |
-30.99% | 11.87B |
- Stock Market
- Equities
- ALB Stock
- News Albemarle Corporation
- Albemarle Corporation Revises Earnings Guidance for the Fiscal Year 2022